The role of the PD-1/PD-L1 signaling pathway in establishing an effective immune response to MTB infection is essential, especially in humans, as many studies have reported the reactivation of TB in cancer patients when given immune inhibition therapy [29,30]. Here, CD274 is linked to tuberculosis.